Associate Director, US Real-World Evidence and Health Outcomes – Oncology Pipeline
GSK
6 months ago
Remote friendly (Philadelphia, PA)
United States
Market Access
Responsibilities
- Co-develop and maintain US RWE & HO plans for 1–2 priority pipeline assets/indications aligned to US medical, payer, and access needs; develop workplans, timelines, and resourcing proposals; provide backup portfolio support as needed.
- Lead day-to-day real-world evidence (RWE) and health outcomes (HEOR) studies, including real-world evidence studies, cost-effectiveness/budget impact analyses, burden of illness, treatment patterns, and patient-focused outcomes; manage design and execution with internal partners and external vendors.
- Support cross-functional evidence strategy forums and asset meetings by preparing agendas/materials, surfacing options, documenting decisions, and tracking actions to closure.
- Draft/review project specifications, protocols, statistical analysis plans, study reports, abstracts, posters, and manuscripts; ensure adherence to SOPs and high scientific/operational quality.
- Provide trial design input to ensure US-relevant patient populations and endpoints/outcomes (e.g., HRQoL, PROs, resource utilization) are collected.
- Provide RWE & HO input to internal decision-making during development and commercialization planning (e.g., trial design considerations, data gap assessments, value messages, evidence prioritization/sequencing).
- Contribute ~20% effort to US RWE & HO strategy and execution for a marketed oncology product in endometrial and rectal cancer, including data generation planning and delivery of analyses/publications supporting lifecycle needs and value communication.
- Generate external insight by aligning with Field Based Payer Medical Teams and other field stakeholders; incorporate insights into evidence plans and value communication.
- Manage vendors and contractors (scope, timelines, budget tracking, change control); proactively escalate risks/issues.
- Complete required training, adhere to SOPs, and contribute to continuous improvement for efficient planning/execution/dissemination of RWE & HO deliverables.
Basic Qualifications (Required)
- Master’s degree or PhD in health economics and outcomes research, epidemiology, public health, biostatistics, or related discipline.
- 1–3 years’ experience in pharmaceutical industry and/or managed care/hospital/academic/healthcare consulting with HEOR/RWE strategy and application exposure.
- Knowledge of US payer/reimbursement and access environment and how payer evidence needs inform evidence planning/deliverables (e.g., value evidence strategy, AMCP-style dossier content, budget impact/cost-effectiveness, payer-focused materials).
- Expertise in RWE and economic evaluation study designs/methods (e.g., study concept/protocol development; clear research questions/endpoints/data source selection; bias/confounding mitigation; reviewing/authoring SAPs and study reports; publication/disclosure readiness per SOPs and external requirements).
- Strong communication/presentation skills with decision-oriented materials and senior-audience readouts.
- Ability to prioritize and manage multiple projects in a matrix environment.
Preferred Qualifications
- Demonstrated success delivering high-quality health outcomes research and data generation outputs.
- Oncology experience (US or global) and familiarity with evolving standards of care, evidence requirements, and stakeholder needs.
- Masters+ (4–6 years) or PhD (2–4+ years) with additional collaboration with field-facing teams and/or Market Access partners.
- Experience managing real-world data sources and vendors (claims, EHR, registries) and translating findings into actionable insights/value messages.
- Ability to influence without authority; align stakeholders on objectives/trade-offs and drive actions to closure.
- Strategic execution experience translating evidence strategy into workplans and delivering outputs across 1–2 concurrent asset streams.
- Project/vendor management experience (scope/success criteria, budget/timelines, risk identification, mitigation via change control).
- Experience with congress strategy and publication planning (abstracts, posters, manuscripts).
Work model
- Hybrid role in the United States with in-office collaboration and remote work flexibility.
How to apply
- Apply and describe how experience in economic modeling and real-world evidence supports access and better patient outcomes.
- Co-develop and maintain US RWE & HO plans for 1–2 priority pipeline assets/indications aligned to US medical, payer, and access needs; develop workplans, timelines, and resourcing proposals; provide backup portfolio support as needed.
- Lead day-to-day real-world evidence (RWE) and health outcomes (HEOR) studies, including real-world evidence studies, cost-effectiveness/budget impact analyses, burden of illness, treatment patterns, and patient-focused outcomes; manage design and execution with internal partners and external vendors.
- Support cross-functional evidence strategy forums and asset meetings by preparing agendas/materials, surfacing options, documenting decisions, and tracking actions to closure.
- Draft/review project specifications, protocols, statistical analysis plans, study reports, abstracts, posters, and manuscripts; ensure adherence to SOPs and high scientific/operational quality.
- Provide trial design input to ensure US-relevant patient populations and endpoints/outcomes (e.g., HRQoL, PROs, resource utilization) are collected.
- Provide RWE & HO input to internal decision-making during development and commercialization planning (e.g., trial design considerations, data gap assessments, value messages, evidence prioritization/sequencing).
- Contribute ~20% effort to US RWE & HO strategy and execution for a marketed oncology product in endometrial and rectal cancer, including data generation planning and delivery of analyses/publications supporting lifecycle needs and value communication.
- Generate external insight by aligning with Field Based Payer Medical Teams and other field stakeholders; incorporate insights into evidence plans and value communication.
- Manage vendors and contractors (scope, timelines, budget tracking, change control); proactively escalate risks/issues.
- Complete required training, adhere to SOPs, and contribute to continuous improvement for efficient planning/execution/dissemination of RWE & HO deliverables.
Basic Qualifications (Required)
- Master’s degree or PhD in health economics and outcomes research, epidemiology, public health, biostatistics, or related discipline.
- 1–3 years’ experience in pharmaceutical industry and/or managed care/hospital/academic/healthcare consulting with HEOR/RWE strategy and application exposure.
- Knowledge of US payer/reimbursement and access environment and how payer evidence needs inform evidence planning/deliverables (e.g., value evidence strategy, AMCP-style dossier content, budget impact/cost-effectiveness, payer-focused materials).
- Expertise in RWE and economic evaluation study designs/methods (e.g., study concept/protocol development; clear research questions/endpoints/data source selection; bias/confounding mitigation; reviewing/authoring SAPs and study reports; publication/disclosure readiness per SOPs and external requirements).
- Strong communication/presentation skills with decision-oriented materials and senior-audience readouts.
- Ability to prioritize and manage multiple projects in a matrix environment.
Preferred Qualifications
- Demonstrated success delivering high-quality health outcomes research and data generation outputs.
- Oncology experience (US or global) and familiarity with evolving standards of care, evidence requirements, and stakeholder needs.
- Masters+ (4–6 years) or PhD (2–4+ years) with additional collaboration with field-facing teams and/or Market Access partners.
- Experience managing real-world data sources and vendors (claims, EHR, registries) and translating findings into actionable insights/value messages.
- Ability to influence without authority; align stakeholders on objectives/trade-offs and drive actions to closure.
- Strategic execution experience translating evidence strategy into workplans and delivering outputs across 1–2 concurrent asset streams.
- Project/vendor management experience (scope/success criteria, budget/timelines, risk identification, mitigation via change control).
- Experience with congress strategy and publication planning (abstracts, posters, manuscripts).
Work model
- Hybrid role in the United States with in-office collaboration and remote work flexibility.
How to apply
- Apply and describe how experience in economic modeling and real-world evidence supports access and better patient outcomes.